Tag Archives: Tuberculosis

Recent update on TB diagnostic techniques – GenXpert MTB/RIF Ultra

Guest posting: Dr Ian Marr, Microbiology Registrar, Pathology NSW, Hunter The GenXpert used in most LMIC has cartridges for detection of Mycobacterium tuberculosis (MTB) – GenXpert MTB/RIF. These contain primers and molecular beacon probes for the detection of both MTB … Continue reading

Posted in Module- Mycobacteria | Tagged , | Leave a comment

Tuberculosis- drug resistant- online learning, mailing lists and references

Courtesy of Dr Suman Majumdar, Dr Catherine Berry and others. Therapeutics Recent presentation from our advanced trainee registrar concerning the new TB drugs: Brian_Chong 2017 New TB drugs. TB drug monographs :  up-to-date clinical profiles of TB drugs including guidance on … Continue reading

Posted in Infectious diseases, Module- Mycobacteria, Mycobacteria tuberculosis | Tagged | Leave a comment

Excellent new Lancet series of tuberculosis papers

See this recent Lancet edition.  Article list below. Editorial comment Richard Horton et al (excerpt) : This latest Lancet Series is led by Salmaan Keshavjee, from Harvard Medical School’s Department of Global Health and Social Medicine. He helped bring together … Continue reading

Posted in Journal | Tagged | Leave a comment

Antimicrobial resistance: WHY it matters, HOW did it arise and WHAT can we do about it – PNG focus

Global status of AMR with focus on PNG Medical Symposium Sept 2015 Why does AMR matter? Antimicrobial resistance kills- mortality higher for resistant pathogens AMR hampers the control of infectious diseases – prolonged infectivity – eg. MDR-TB AMR increases the … Continue reading

Posted in A/m resistance, A/m stewardship, Infection prev & control, PNG | Tagged , | Leave a comment

Tuberculosis infection control – an essential priority

Control of healthcare TB transmission is an essential element of practice – protecting staff and other patients is paramount. Patients receiving drug therapy for drug susceptible TB are at increased risk for acquisition of MDR or XDR TB. WHO policy on … Continue reading

Posted in Bacteria (GPOS), Module- Mycobacteria, Tuberculosis infection control | Tagged | Leave a comment